Clinical trial · Observational
Correlation of Gene Status and Clinical Outcomes in ESCC
Retrospective Study of Gene Status and Clinical Outcome of Esophageal Squamous Cell Carcinoma(ESCC).
NCT03831828CI-TRIAL-00037004ESCCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prognosis of Patients With ESCC | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Lymph node metastasis Positive
- description
- good prognosis; without Lymph node metastasis.
- label
- Lymph node metastasis Negative
- description
- poor prognosis; with Lymph node metastasis.
Primary outcomes (1)
- measure
- Gene test
- timeFrame
- 2019-2 to 2019-4
- description
- 466 Tumor-associated gene test by next-generation sequencing(NGS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information. Exclusion Criteria: * Patients who also suffering from other tumors.
References
Publications (0)
Data not yet available
No reference posted for this study.